Early Growth Response Gene-2 (Egr-2) Regulates the Development of B and T Cells by Li, SL et al.
Early Growth Response Gene-2 (Egr-2) Regulates the Development of B
and T Cells
Li, SL; Symonds, ALJ; Zhu, B; Liu, MY; Raymond, MV; Miao, TZ; Wang, P
 
 
 
 
 
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/jspui/handle/123456789/4827
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
Early Growth Response Gene-2 (Egr-2) Regulates the
Development of B and T Cells
Suling Li1*, Alistair L. J. Symonds2, Bo Zhu2,3, Mengya Liu1, Meera V. Raymond2, Tizong Miao2, Ping
Wang2*
1Department of Biosciences, Brunel University, Uxbridge, London, United Kingdom, 2 Institute of Cell and Molecular Science, Barts and London School of Medicine and
Dentistry, University of London, London, United Kingdom, 3 Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, People’s Republic of China
Abstract
Background: Understanding of how transcription factors are involved in lymphocyte development still remains a challenge.
It has been shown that Egr-2 deficiency results in impaired NKT cell development and defective positive selection of T cells.
Here we investigated the development of T, B and NKT cells in Egr-2 transgenic mice and the roles in the regulation of
distinct stages of B and T cell development.
Methods and Findings: The expression of Egr1, 2 and 3 were analysed at different stages of T and B cell development by
RT-PCT and results showed that the expression was strictly regulated at different stages. Forced expression of Egr-2 in CD2+
lymphocytes resulted in a severe reduction of CD4+CD8+ (DP) cells in thymus and pro-B cells in bone marrow, which was
associated with reduced expression of Notch1 in ISP thymocytes and Pax5 in pro-B cells, suggesting that retraction of Egr-2
at the ISP and pro-B cell stages is important for the activation of lineage differentiation programs. In contrast to reduction of
DP and pro-B cells, Egr-2 enhanced the maturation of DP cells into single positive (SP) T and NKT cells in thymus, and
immature B cells into mature B cells in bone marrow.
Conclusions: Our results demonstrate that Egr-2 expressed in restricted stages of lymphocyte development plays a
dynamic, but similar role for the development of T, NKT and B cells.
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Introduction
T and B cell development in the thymus or bone marrow is a
strictly controlled process that requires the precise alternation of
gene expression programs orchestrated by specific transcription
factors [1,2]. T and B cells initially develop from lymphoid-primed
multipotent progenitors (LMPP) [3]. The current paradigm is that
as the cells develop, the changes induced by newly synthesized
transcription factors dictate lineage differentiation and maturation
of T or B cells [3]. Although some major transcription factors have
been defined for lineage commitment, such as EBF1 and Pax5 for
B cells and Notch1 for T cells, the transcription factors that are
specifically involved in the regulation of distinct stages of B and T
cell development are largely unknown [1,2].
Egr-1 and Egr-3 induced by pre-TCR signaling have been
found to be important for the DN to DP transition
[4,5,6,7,8,9,10]. Among the four members of the Egr family,
Egr-1, -2 and -3 are expressed during thymocyte development
[4,5]. Overexpression of Egr-1 or Egr-3 in pre-TCR deficient mice
partially restores the progression through the b-selection check
point [4,7,11,12], and induces downregulation of Rag1, Rag2 and
pTCRa, resembling some characteristics of the endogenous effects
of pre-TCR signaling. Mice deficient in Egr-1 or in Egr-2 have
normal b-selection, but a defect in positive selection [6,10,13],
while Egr-3 deficient thymocytes have a partial block at the DN3
stage that is largely due to defective proliferation of DN4 cells [7].
Interestingly, mice lacking both Egr-1 and Egr-3 had a severe
reduction of thymocyte numbers, with reduction of the DN4/DN3
ratio [14]. The low thymic cellularity is due to massive apoptosis of
thymocytes resulting from an autonomous survival defect [14],
which has not been seen in single knockout models [7,6],
suggesting a redundant function between these two Egr molecules.
A similar function of Egr-1 and Egr-3 in thymocyte development is
further supported by an identical phenotype in Egr-1 and Egr-3
transgenic models [8,11].
Like Egr-1 and -3, Egr-2 has also been found to be induced by
pre-TCR signaling in DN3 thymocytes [4]. Overexpression of
Egr-2 in vitro induces downregulation of Rag1 and Rag2 gene
expression [4], indicating an overlapping function between Egr-2
and Egr-1 and Egr-3. In an adoptive transfer model with fetal liver
cells from Egr-2 KO mice, the reconstituted thymocytes in
Rag22/2 mice have normal development of conventional T
cells, but a defect in NKT cell development [15]. We have recently
developed a CD2-specific Egr-2 KO model and did not find
changes in T cell development [16]. To investigate further the
function of Egr-2 in the development of lymphocytes, we
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established CD2-specific Egr-2 transgenic (Egr-2 cTg) mice. We
discovered a defect in thymocyte development in Egr-2 cTg mice
which was remarkably similar to that in Egr-1 and Egr-3
transgenic mice [8,11]. However, we discovered two important
novel functions of Egr-2; enhancement of DP cell maturation into
SP and NKT cells, and regulation of B cell development.
Intriguingly, the defects in B cell development observed in Egr-2
cTg mice resembled those seen in thymocytes in these mice
suggesting that Egr-2 may have a similar mechanism of action in
these two cell types. The defects in thymocyte and B cell
development are accompanied by reduced expression of lineage
regulators, Notch1 in ISP thymocytes and Pax5 in Pro-B cells in
Egr-2 cTg. Our results demonstrate a general function of Egr-2 in
regulation of lymphocyte development, suggesting that Egr-2
expressed in restricted stages of lymphocyte development plays a
dynamic role for the regulation of progenitors and the maturation
of lymphocytes.
Materials and Methods
Mice
Egr-2 cKO mice, a line with deletion of Egr-2 in CD2+
lymphocytes on a B6 background, were described in our previous
publication [16]. B6 mice were purchased from Harlan UK Ltd.
(Oxon, England). To generate Egr-2 transgenic mice, the Egr-2
coding region, and flanking EcoRI site, was amplified by PCR
with primers (sense TGACGAATTCATGATGACCGCCAA-
GGC and anti-sense CACACCCTAACTGACACACATTCC)
from an Egr-2 expression construct containing Egr-2 cDNA [16].
The PCR product was cloned into the hu-CD2 vector containing
the human CD-2 promoter [17]. A vector free DNA fragment
containing the human CD-2 promoter, hCD2 LCR, Egr-2 cDNA
and poly-A signal was injected into pronuclei of fertilized oocytes
from C57BL/6xCD1 F1 mice by the transgenic core facility at
Barts and The London Medical School, Queen Mary University
of London. Transgenic founders were detected by PCR analysis of
genomic tail DNA with primers: sense CCACCAGTCTCACTT-
CAGTTCC and anti-sense CAGCTGGTGCATAAAACCAC-
TG. The transgenic lines were propagated by sequential crossing
to C57BL/6 mice. Two transgenic founder lines, Tg14 and Tg18,
both expressing high levels of the Egr-2 transgene and displaying
similar phenotypes, were derived from C57BL/6. All mice were
maintained in the Biological Services Unit, Barts and The London
School of Medicine, and used according to established institutional
guidelines under the authority of a UK Home Office project
licence (Guidance on the Operation of Animals, Scientific
Procedures Act 1986). The Tg14 line was used for most of the
experiments and termed Egr-2 cTg.
Flow cytometry and antibodies
Flourescein isothiocyanate (FITC)-conjugated antibodies to
B220, CD4, CD8 and TCRb; phycoerythrin (PE)-conjugated
antibodies to CD3, CD4, CD5, CD8, CD19, CD25, CD43,
CD127, IgM and NK1.1; PerCP labelled antibody to CD3,
NK1.1, CD19, B220; allophycocyanin (APC)-conjugated antibod-
ies to TCRb, NK1.1, CD43, CD44, CD3, CD19 and APC-
conjugated Annexin V were obtained from BD Biosciences. PE-
conjugated pre-loaded CD1 tetramer was from ProImmune.
Single cell suspensions were prepared from 6–10 wk old mice.
For staining, 26106 cells were stained with optimal amounts of
fluorochrome-labelled antibodies and analyzed on a LSRII (BD
Immunocytometry Systems) and the data were analyzed using
FlowJo (Tree Star). Cell sorting was performed on a FACSAria
sorter with DIVA option (BD Immunocytometry Systems).
Quantitative real-time PCR
Real time PCR was carried out as described [16]. Briefly, total
RNA was extracted from total thymocytes or FACS sorted DN1,
DN2, DN3, DN4, DP or ISP cells and total bone marrow cells or
FACS sorted pre-pro-B, pro-B, pre-B, immature-B and mature-B
cells, using TRIzol (Invitrogen Life Technologies), and was reverse
transcribed using oligo(dT) primers (Amersham Biosciences).
Quantitative real-time PCR was performed on a Rotor-Gene
system (Corbett Robotics) using SYBR green PCR master mix
(Qiagen). The primers used in quantification of gene expression
were; Egr-2; sense 59-CTTCAGCCGAAGTGACCACC-39; anti-
sense 59-GCTCTTCCGTTCCTTCTGCC-39, E2F2; sense 5-GT-
AGAAGAGGGTGTGACAGC-3; antisense 5-AGCACTGACT-
CTGGGATCGC-3, Bcl2; sense 5-GGAGAAATCAAACAGAG-
GTCGC-3; antisense 5-CGTCAACAGGGAGATGTCACC-3,
BclXL; sense 5-CATTGTTCCCGTAGAGATCC-3; antisense 5-
TTCGGGATGGAGTAAACTGG-3, c-MYB; sense 5-GTTCT-
TAGGTACGGTAAAGGC-3 antisense 5-TTCTTCTGCTCA-
AACCACTGG-3, c-MYC; sense 5-AGGGGTTTGCCTCTT-
CTCCAC-3 antisense 5-TTCTCTCCTTCCTCGGACTCG-3,
RORgt sense 5-CCGCTGAGAGGGCTTCAC-3; antisense 5-
TGCAGGAGTAGGCCACATTACA-3, Notch1 sense 5- CAGC-
TTGCACAACCAGACAGAC-3, anti-sense 5-ACGGAGTACG-
GCCCATGTT-3, TCF1 sense 5-TGCTGTCTATATCCGCAG-
GAAG-3, anti-sense 5-CGATCTCTCTGGATTTTATTCTCT-
3, Gata2 sense 5-TGCAACACACCACCCGATACC-3, antisense
5-CAATTTGCACAACAGGTGCCC-3, Gata3 sense 5-GAGG-
TGGTTGTCTGC-3, antisense 5- TTTCACAGCACTAGAGA-
CCCTGTTA-3, Runx1 sense 5-CCTGCTTGGGTGTGAG-
GCCC-3, antisense 5-GCCTCGCTCATCTTGCCGGG-3, b-
actin sense 5-AATCGTGCGTGACATCAAAG-3, antisense 5-
ATGCCACAGGATTCCATACC-3, ICER sense 5-GCTAG-
TTGGTACTGCCATGGTAGC-3, antisense 5-AGCCCAACA-
TGGCTGTAACTGGAG-3, Nor1 sense 5-AGGATACACTT-
CCTGTGTCAAGGG-3, antisense 5-CCATTTCATAGCAT-
GACTGCCTCC-3, Nurr1 sense 5-GCAGTTGCTTGACACG-
CAGGTGCC-3, antisense 5-CCTGTGGGCTCTTCGGCTT-
CGAGG-3, Nur77 sense 5-GCTATTCCATGCCAGCAGCT-
TTCC-3, antisense 5-CCGTACAACTTCCTTCACCATGCC-
3, Rag1 sense 5-ACCTGAGATCGATGATCCCACATCT-3,
antisense 5-CTGTCGATTCTCGAGTATGGAAGTC-3, Rag2
sense 5-AGACCCGTTTGAGCTACTTCTTGC-3, antisense 5-
GGAGCTTCCTTCTCTATGAAGTCG-3, Egr1 sense 5-AC-
GACAGCAGTCCCATCTACTCGG-3, antisense 5-GGACTC-
GACAGGGCAAGCATATGG-3, LTa sense 5-GTCTGG-
TTCTCCACATGACACTGC-3, antisense 5-GAAAAGAGCTG-
GACCTCGTGTGCC-3, Egr3 sense 5-CGACTCGGTAGCC-
CATTACAATCAGA-3, antisense 5-GAGATCGCCGCAGT-
TGGAATAAGGAG-3, LTb sense 5-TGCCTATCACTGTCC-
TGGCTGTGC-3, antisense 5-AACGCTTCTTCTTGGCTC-
GCCTCC-3, LTbR sense 5-CTACCCATGTCTGGAGACTTG-
TCC-3, antisense 5-CTGTCAGAGGTCTTGGCATCCTAG-3,
LIGHT sense 5-TCAGCTGCTCTGGCATGGAGAGTG-3, an-
tisense 5-TGCTGGGTTGGCCTGGTGAGATCG-3, AIRE
sense 5-GATGTGGACCTAAACCAGTCCCGG-3, antisense 5-
CTGGCTTTAGGCTGCTACCACTCC-3, Pax5 sense 5-CCA
TCAGGACAGGACATGGAG-3, antisense 5-GGCAAGTTC
CAC TAT CCT TTG-3. LEF-1 sense 5- TCCCTAGCCA-
CAGTCCAATA-3, anti-sense 5- AGCAACAGGCTTAGAAC-
GTG-3, Id1 sense 5-TACTTGGTCTGTCGGAGCAA-3, anti-
sense 5-GATCAAACCCTCTACCCACT-3, Id2 sense 5-CC-
TGGACTCGCATCCCACTA-3, antisense 5-TGCTATCATTC-
GACATAAGCTCAGA-3, Id3 sense 5-ATCCTGCAGCGTGT-
CATAGACT-3, antisense 5-AGGCGTTGAGTTCAGGG-
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TAAGT-3, HEB sense 5-AAATCAGATGATGAGTCCTCCC-3,
anti-sense 5-CTCTGGAACTGGCTGATGTTT-3, E2A sense 5-
GCATAGGAAGCTCAGCAGAGA-3, anti-sense 5-AAGCATA-
CAGGACTGCAAGGAG-3.
The data were analyzed using the Rotor-Gene Software. All
samples were run in duplicate, and relative mRNA expression
levels were obtained by normalizing against the level of b-actin
from the same sample under the same program using: relative
expression = 2(CTb-actin-CTtarget)610,000.
TUNEL assay
Anesthetized mice received intracardiac PBS followed by
aldehyde perfusion (4% paraformaldehyde in PBS). The thymus
were removed and frozen in OCT embedding medium (VWR)
and stored in liquid nitrogen. TUNEL assay was performed
with TACSTM TdT Kit (Roche Diagnostics GmbH, Roche
Applied Science, Mannheim, Germany) as per the manufactur-
er’s protocol. Briefly, cryosections were fixed with 3.7%
formaldehyde solution, to prevent the loss of low molecular
weight DNA fragments, and then the cell membranes were
permeabilized with Proteinase K. Apoptotic cells were then
labelled in situ by addition of biotinylated nucleotides onto the
3-OH ends of the DNA fragments by Terminal deoxynucleo-
tidyl Transferase (TdT). The biotinylated nucleotides were
detected using a streptavidin-fluorescein conjugate. The fluores-
cein-stained cells were subsequently visualized using a fluores-
cence microscope.
Statistics
The Mann-Whitney U test was used. The normality of data
distribution and the homogeneity of variances of the data were
verified by the K-S Lilliefors and Cochran C tests, respectively.
Results
Sustained expression of Egr-2 affects thymocyte
development
Despite expression of Egr-2 in thymocytes, deletion of Egr-2 in
CD2+ lymphocytes (Egr-2 cKO) did not alter the development of
thymocytes [15 and 16]. To further analyze the function of Egr-2
in lymphocytes, two CD2-specific Egr-2 transgenic (Egr-2 cTg)
lines were established (Fig. 1A and B).
The size of the thymus in Egr-2 cTg mice was only one third of
wild type mice (Fig. 1C) with increased CD42CD82 DN and
CD42CD8+CD32 ISP, but severely reduced CD4+CD8+ DP cells
(Fig. 1 D, E, Fig. 2 A). Although the changes in percentages of
thymocyte subsets were strikingly similar to those in Egr-1 and
Egr-3 transgenic mice [8,11], the changes in absolute number of
DN subsets differed [8,12]. In contrast to the normal number of
DN1 and DN2 cells, the absolute number of DN3 and DN4 cells
Figure 1. Defective thymus development in Egr-2 transgenic mice. A). confirmation of presence of transgene by PCR. B). expression of Egr-2
in thymocytes from wild type, Egr-2 cKO and two Egr-2 cTg mouse lines (14 and 18) determined by quantitative RT-PCR. The relative expression was
measured after normalization against b-actin. * Egr-2 was not detected in Egr-2 cKO T cells. C). Thymus size in wild type, Egr-2 cTg and Egr-2 cKO
mice. D). Thymocytes from wild type and Egr-2 transgenic mice were stained with anti-CD4 and anti-CD8. E). Expression of CD3, TCRb and CD5 by
gated CD4+ or CD8+SP T cells in thymus. The data are representative of three experiments in which 3 to 5 mice from each group were used.
doi:10.1371/journal.pone.0018498.g001
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in Egr-2 cTg mice were double that of wild type mice (Fig. 2 B and
C) despite a similar level of Egr-2 transgene expression (Figure S1).
Interestingly, in contrast to the reduction of DP cells in the thymus,
the percentage of DP cells that matured into SP cells was increased
(Fig. 2D). The T cell subsets in the periphery were also altered and
resembled that seen in the thymus (Fig. 2E, F). Although Egr-2 has
been found to induce expression of FasL on activated T cells [18],
the expression of FasL was normal (data not shown) and a normal
apoptosis was detected in Egr-2 cKO and Egr-2 cTg thymus (Fig. 3A
and B). We investigated the proximal signalling of T cell receptor
and proliferation of thymocytes following stimulation with anti-CD3
in vitro and a similar result was found in thymocytes from wild type
and Egr-2 cTg mice (Figure S2). These results suggest that Egr-2
plays different roles at the early and late stages of thymocyte
development and the function of Egr-2 may not associate with cell
death and TCR signalling.
Forced expression of Egr-2 enhances NKT cell
development
NKT cells develop from DP cells and it has been found recently
that Egr-2 induced by NFAT is important for NKT cell
development [15]. We found that the development of NKT cells,
detected as NK1.1+TCRb+ or CD1 tetramer+TCRb+, in Egr-2
cKO mice was comparable to that in wild type mice, while
increased in Egr-2 cTg mice (Fig. 4A). Despite the severe
reduction in the DP population, the absolute number of NKT
cells in the thymus of Egr-2 cTg mice was similar to that in wild
type mice (Fig. 4B). Therefore, the ratio of NKT/DP cells in Egr-2
cTg mice was significantly increased (Fig. 4C) suggesting that in
addition to the enhanced maturation of DP cells into SP T cells,
Egr-2 enhances the maturation of DP cells into NKT cells. Our
results suggest that Egr-2 supports the maturation of DP cells to T
or NKT cells.
Sustained Egr-2 expression blocks the development of
pre-pro-B cells into pro-B cells, but enhances B cell
maturation
It is unknown whether Egr-2 is involved in B cell development.
The CD2 promoter used to create Egr-2 cKO and cTg mice is
active in both T and B lymphocytes [17]. Therefore, B cell
development was also examined in these mice. Similar to
thymocyte development, the development of B cells in the bone
Figure 2. Development of thymocytes. A). Absolute number of thymocyte subpopulations in thymus. The ISP cells were defined as
CD42CD8+CD32 (see Fig. 1E). B). The subpopulations of DN cells in thymus were examined by analysis of CD25 and CD44 expression on gated
CD42CD82 DN cells. C). Absolute number of DN subsets in thymus. D). Percentage of CD3+DP cells that develop into CD3+CD4+ or CD3+CD8+ cells in
thymus. E). Subpopulations of T cells in lymph nodes and spleen. F). Expression of CD3, TCRb and CD5 on CD4+ or CD8+ cells in spleens. * p,0.001.
The data are representative of more than three experiments in which 3 to 5 mice from each group were used.
doi:10.1371/journal.pone.0018498.g002
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marrow was normal in Egr-2 cKO mice, but severely defective in
Egr-2 cTg mice (Fig. 5). Subsequently, a reduction of B cells in the
peripheral lymphoid organs of Egr-2 cTg mice was detected
(Fig. 5A). In the bone marrow pre-pro-B cells, defined by a
NK1.12B220+CD192CD43+ phenotype, were slightly increased
in Egr-2 cTg mice, while pro-B cells, defined by
NK1.12B220+CD19+CD43+, pre-B cells, NK1.12B220+CD432,
and immature-B cells, NK1.12B220+IgM+, were severely reduced
(Fig. 5B). However, in contrast to the severe defects in pro-, pre
and immature B cells, the number of mature B cells, defined by
NK1.12B220highIgM+, in the bone marrow in Egr-2 cTg mice
was normal (Fig. 5A and B). Therefore, similar to the enhanced
maturation of DP cells into SP and NKT cells in the thymus, the
ratio of mature/immature B cells in the bone marrow showed that
more than 60% of immature B cells developed into mature B cells
while only 20% did in wild type mice (Fig. 5C). The levels of Egr-2
transgene expression were similar in different stages of B cells
(Figure S1). Thus, we have discovered that Egr-2 does not
Figure 3. Thymocyte apoptosis. A). Tunel assay on thymus of wild type, Egr-2 cTg and Egr-2 cKO mice. B). Percentage of Annexin V+ and PI2
thymocytes in wild type, Egr-2 cTg and Egr-2cKO mice. The data are representative of three to five mice.
doi:10.1371/journal.pone.0018498.g003
Figure 4. Development of NKT cells in thymus. A). Thymocytes from wild type, Egr-2 cKO and Egr-2 cTg mice were stained with NK1.1 and TCRb
antibodies (top) or with TCRvb and CD1 tetramer (bottom). B). Absolute numbers of NKT cells in thymus of Egr-2 cKO, Egr-2 cTg and wild type mice.
C). Percentages of DP cells that develop into NKT cells in thymus of Egr-2 cKO, Egr-2 cTg and wild type mice. * p,0.001. The data are representative
of more than two experiments in which 3 to 5 mice from each group were used.
doi:10.1371/journal.pone.0018498.g004
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specifically function in the development of the T cell lineage, but
also in B cells and has a similar effect in both lineages.
Expression of Egr molecules is modulated during
lymphocyte development
Previous reports show that Egr-1, -2 and -3 are expressed in DN
cells [4]. The defects in thymocyte and B cell differentiation in
Egr-2 cTg mice suggest that Egr expression is strictly modulated at
different stages of thymocyte and B cell development. Therefore,
the expression of Egr-1, -2 and -3 was analyzed in thymocytes and
bone marrow B cells from wild type mice at different stages. Egr-2
and Egr-3 were expressed at relatively high levels while the levels
of Egr-1 were much lower at all stages of DN cells in the thymus
(Fig. 6A), while Egr-2 was significantly higher than Egr-1 and Egr-
3 in B2202CD192CD127+ common lymphoid progenitors (CLP)
and pre-pro-B cells (Fig. 6B). However, the expression profile of
these three Egr molecules across the different stages was essentially
identical. They were all expressed in DN2, DN3 and DN4
thymocytes as well as CLP and pre-pro-B cells, while the
expression was minimal in ISP and pro-B cells (Fig. 6A and B).
The comparable expression profiles correlate well with the similar
defects in DP thymocytes in all three Egr transgenic mice [8,11]
and taken together provide strong evidence for a redundant role of
these molecules. Importantly, these results indicate that the
silencing of Egr expression at the ISP and pro-B cell stages is
critical for the differentiation of thymocytes and B cells.
Over-expression of Egr-2 impairs Notch1 and Nur77
expression in ISP thymocytes and Pax5 in pro-B cells
Lymphocyte development consists of an irreversible progression
of cells through distinct developmental stages which is regulated by
the coordinated expression of a multitude of transcription factors
[1,2,19]. We have now shown that Egr molecules are expressed in
the early stages of T and B cell development and that the
expression was reduced at the ISP thymocyte and pro-B cell stages.
Egr-1 has been found to induce expression of Id3, a helix-loop-
helix protein [20]. Together with E2A, Id proteins are important
for the early development of B and T lymphocytes [21]. To
investigate the possible role of Egr-2 in the expression of regulatory
genes in thymocyte and/or B cell development, we analyzed the
Figure 5. B cell development. A). Cells from bone marrow, lymph nodes and spleen of wild type, Egr-2 cKO and Egr-2 cTg mice were co-stained
with anti-CD19 and anti-B220 (left) or anti-IgM and anti-B220 (right). B). Absolute number of B cell precursor subpopulations in bone marrow of wild
type, Egr-2 cKO and Egr-2 cTg mice. Pre-pro-B cells defined as NK1.12B220+CD192CD43+, pro-B cells defined as NK1.12B220+CD19+CD43+, pre-B cells
as NK1.12B220+CD432, immature B cells as NK1.12B220+IgM+ and mature B cells defined as NK1.1-B220highIgM+. C). Percentages of immature B cells
that develop into mature B cells in bone marrow. * p,0.001. The data are representative of more than two experiments in which 3 to 5 mice from
each group were used.
doi:10.1371/journal.pone.0018498.g005
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expression of several well characterized regulatory genes, including
E2F2, Bcl2, BclXL, E2A, Id1, Id2, Id3, MYB, c-Myc, RORgt,
Gata2, Gata3, Runx1, ICER, AIRE, TCF1, LEF-1, HEB,
Notch1, Nurr1, NUR77, PAX5 and LEF-1 [1,19], in DN and
ISP thymocytes and pro-B cells from Egr-2 cTg and wild type
mice. The expression of most of the genes tested was unchanged
(data not shown). However, the expression of Notch1 was reduced
in ISP cells from Egr-2 cTg mice (Fig. 6C). In addition to Notch1,
the expression of the orphan nuclear receptor Nur77 was defective
in ISP cells from Egr-2 cTg mice (Fig. 6C). Interestingly, the
expression of Pax5, which is required for B cell lineage
commitment and differentiation, was reduced in pro-B cells from
Egr-2 cTg mice (Fig. 6D). These results suggest that withdrawal of
Egr expression at the early stages of lymphocyte development is
important for the final development of T and B cells.
Discussion
Egr-2 has been found to be important for NKT cell
development and positive selection of thymocytes in separate
studies [10,13,15]. We have now shown that together with Egr-1
and Egr-3, Egr-2 is expressed only in selected stages of T and B
cell development and is repressed in ISP thymocytes and pro-B
cells. Forced expression of Egr-2 severely impairs the development
of DP cells in thymus and immature B cells in bone marrow,
respectively. In contrast to the defects in precursor development in
Egr-2 cTg mice, the percentage of DP cells developed into SP and
NKT cells and the percentage of immature B cells into mature B
cells were increased, suggesting that Egr-2 has a general role in the
regulation of progenitors and terminal maturation of lymphocytes,
but at restricted stages.
Expression of Egr-1, -2 and -3 molecules can be induced in DN
cells upon pre-TCR stimulation [4]. The involvement of Egr
proteins in b-selection is demonstrated by the fact that
overexpression of Egr-1 or Egr-3 can overcome the deficiency in
b-selection resulting from Rag deficiency and drives the
development of cells to the ISP stage [7,11]. However, the most
significant and common phenotype displayed in transgenic models
of Egr-1, -2 and -3 is the reduction of the DP population and the
increase of ISP cells [8,11], which suggests that Egr molecules are
important for the development of DN cells following b-selection
and withdraw of Egr-2 expression after b-selection is important for
the differentiation of ISP cells to DP cells. Although Egr-1 or Egr-2
deficiency does not affect thymocyte development significantly
[6,10,16], Egr-3 deficiency results in thymic atrophy due to
impaired proliferation after b-selection, but the DN to DP
transition is normal [7], indicating an important function of Egr
molecules in supporting expansion and survival of thymocytes
after b-selection. The defects in proliferation and survival of
thymocytes were much more severe in mice lacking both Egr-1
Figure 6. Kinetic expression of Egr in wild type and expression of regulatory genes in thymocytes and bone marrow B cell
precursors from Egr-2 cTg mice. Egr expression as determined by quantitative RT-PCR in subpopulations of thymocytes (A) or bone marrow B cell
precursors (B) of wild type mice. CD8+CD42CD32 ISP cells and CD4+CD8+ DP cells were sorted by FACS. DN cell subpopulations were isolated based
on their expression of CD25 and CD44 after first gating on CD42CD82 cells. B cell subsets were sorted by FACS based on triple staining with
CD192B2202CD127+ for CLP cells, NK1.12B220+CD192CD43+ for pre-pro-B cells, NK1.12B220+CD19+CD43+ for pro-B cells and NK1.12B220+CD432
for pre-B cells. C). Expression of Notch1 and NUR77 genes in DN (CD42CD82) and ISP (CD8+CD32) thymocytes from wild type and Egr-2 cTg mice
determined by quantitative RT-PCR. D). Expression of Pax5 in sub-populations of B cells from bone marrow of wild type and Egr-2 cTg mice. The
relative expression is shown as mean6 s.e.m. for duplicate determinations, relative to actin. * p,0.001. The data are representative of more than two
experiments in which 3 to 5 mice from each group were used.
doi:10.1371/journal.pone.0018498.g006
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and Egr-3 and observed in both DN and DP subsets suggesting a
survival function of Egr molecules at early and late stages of
thymocyte development [14], which is directly supported by our
findings that DN cells and percentage of DP differentiated to SP
and NKT cells are increased in Egr-2 cTg mice. A response of
transient Egr-3 expression to pre-TCR stimulation has been
suggested to be important in order to allow later induction of Bcl-
XL and RORgt since sustained expression of Egr-3 decreases the
expression of Bcl-XL and RORgt [8,9]: important factors for the
survival of mature thymocytes during selection [1]. Therefore,
overlapping with Egr-1 and -2, the regulated expression of Egr-3
in response to pre-TCR stimulation is important for the
maturation of DP cells. The increased maturation of DP cells
into SP and NKT cells in Egr-2 cTg mice indirectly supports the
findings that Egr-2 is important for positive selection and the
development of NKT cells [10,13,15].
Our results extend the function of Egr-2 to the development of
B cells and indicate a similar mechanism for the modulation of
Egr-2 expression and the function of Egr-2 in regulation of B cell
progenitors and B cell maturation. The expression of Egr-1 can
be induced in pre-, immature- and mature-B cells by stimulation
with anti-IgM [22]. However, the expression of Egr in B cell
progenitors is unknown. We have now demonstrated that Egr-1,
-2 and -3 are expressed in CLP and pre-pro-B cells and,
importantly, the expression is repressed in pro-B cells, a similar
expression pattern to that seen in DN and ISP thymocytes. In
addition to the similar expression pattern, the pattern of defects is
also similar between B and T cell development in Egr-2 cTg
mice, as demonstrated by a severe reduction of pro-B cells and
enhanced terminal B cell maturation, suggesting a common
mechanism operated by Egr-2 in both lineages. Despite the
severe defect of pro-B cells in Egr-2 cTg mice, the development of
B cells in Egr-2 cKO mice is normal. This may be due to the
weak activity of the CD2 promoter in B cells as shown previously
or perhaps due to the redundant function of Egr-1 and Egr-3
[14].
The normal expression of the major molecules involved in cell
death and survival (data not shown) and the normal apoptosis of
thymocytes in the thymus indicate that the abnormalities resulting
from sustained Egr-2 expression are not due to increased
apoptosis. Instead the impaired development of DP thymocytes
and pro-B cells appears to be due to the blockade of the
differentiation of early lineage-restricted cells into fully committed
pre-B cells or DP thymocytes. One intriguing possibility is that the
expression of Egr molecules may be inherited from hematopoietic
stem cells and that Egr molecules may serve to support the early
stages of lymphocyte development and are then downregulated
before final commitment to a specific lineage.
It has been reported that Egr-1 induces expression of ID3 [20].
ID3 is one of the ID proteins that modulate function of E2A
proteins [23]. The E2A transcription factors are essential for the
commitment and differentiation of B- and T-lymphocytes [23].
Deficiency in the E2A pathway results in a defective transition of
DN to DP stage as seen in Egr-2 cTg mice [20]. Although E-box –
ID pathways may be regulated by Egr-1, the expression of ID3 is
unchanged in Egr-2 expressing DN and ISP cells (data not shown)
suggesting that Egr-2 does not directly induce ID3 expression.
The involvement of Egr-2 in early development of T and B cells
is supported by the impaired expression of lineage specific
transcription factors Notch1 in thymocytes and Pax5 in pro-B
cells in Egr-2 cTg mice. Activation of the Pax5 and Notch1
pathways is essential for the lineage commitment and maturation
of B and T lymphocytes, respectively [1,2]. Pax5 is exclusively
expressed in the B lymphoid lineage from the committed pro-B
cells to the mature B cell stage and controls the commitment of
lymphoid progenitors to the B cell pathway [2]. Notch signaling is
important during the early development of thymocytes but the
regulation of Notch expression is not clear [1]. Notch1 is highly
expressed at early stages of DN cells and the expression is reduced
after b-selection and downregulated in DP cells [23,24]. Although
both Notch1 and Egr molecules are expressed in DN cells, only
Notch1 is detected in ISP cells. Interestingly, sustained expression
of Egr-2 does not affect Notch1 expression in DN cells, but
reduced it in ISP cells, suggesting that regulation of Notch1 by
Egr-2 is conditional upon other factors and may depend upon the
stage of thymocyte development. Egr-2 has been found to play
different roles in macrophage differentiation based on its
association with PU.1 [25]. PU.1 is expressed in the early stages
of T and B cell development [1,2], and whether PU.1 regulates the
expression and function of Egr-2 in suppression of the Notch and
Pax5 signaling pathways at the early stages of DN or pro-B cell
development, respectively, remains to be investigated. The
enhanced maturation of T, NKT and B cells in Egr-2 cTg mice
could not be explained by the reduced expression of Notch1 in ISP
and Pax5 in pro-B cells. The completely opposite functions of Egr-
2 induced at the early and late stages of lymphocyte development
suggest that the function of Egr-2 may depend on the function of
stage specific transcription factors. The establishment of Egr-1, -2,
-3 null and inducible Egr transgenic mice will be essential to define
the redundant and specific roles of these three Egr molecules at the
early and late stages of lymphocyte development and to
characterize stage specific function.
Supporting Information
Figure S1 Expression of Egr-2 in subsets of thymocytes
(A and B) and B cells (C). Subsets of thymocytes and B cells
were sorted according to surface markers as described in material
and method. Total RNA was used for RT-PCR analysis. The
expression was normalized against actin.
(TIF)
Figure S2 TCR signalling is normal in thymocytes from
wild type and Egr-2 cTg mice. A). Thymocytes were isolated
and stimulated with or without pre-coated anti-CD3 (5 ug/ml) for
60 minutes. Total cell lysates were immunoblotted with antibodies
against pERK or ERK. B). Isolated thymocytes were plated at
56105/well in a 96-well plate pre-coated anti-CD3 and cultured
for three days, then pulsed for 8 hours with 3H-thymidine. The
incorporated of 3H was measured. The experiments were from
thymocytes pooled from five mice.
(TIF)
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